Superparamagnetic iron oxide-enhanced MRI at 3 T for accurate axillary staging in breast cancer
Authors:
- 17 November 2015
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 103 (1) , 60-69
Abstract
Background The aim of this study was to evaluate whether MRI at 3 T with superparamagnetic iron oxide (SPIO) enhancement is an accurate and useful method for detecting metastases in sentinel nodes identified by CT‐lymphography (CT‐LG) in patients with breast cancer. The results were compared with those obtained using CT‐LG alone and diagnosing metastasis according to size criteria. Methods Patients with clinically node‐negative breast cancer were included. Sentinel nodes identified by CT‐LG were evaluated prospectively using SPIO‐enhanced MRI at 3 T. Sentinel node size was measured on CT‐LG, and a node larger than 5 mm in short‐axis diameter was considered metastatic. Sentinel nodes localized by CT‐LG were removed, and imaging results and histopathological findings were compared. Results Sentinel nodes were identified successfully by CT‐LG in 69 (99 per cent) of 70 patients. All 19 patients with a finding of metastasis in sentinel nodes at pathology were also shown to have metastases on MRI. Forty‐eight of 50 patients with non‐metastatic sentinel nodes diagnosed at pathology were classified as having non‐metastatic nodes on MRI. On a patient‐by‐patient basis, the sensitivity, specificity and accuracy of MRI for the diagnosis of sentinel node metastases were 100, 96 and 97 per cent; respective values for CT‐LG were 79, 56 and 62 per cent. The specificity and accuracy of MRI were superior to those of CT‐LG (P < 0·001 and P = 0·002 respectively). Conclusion SPIO‐enhanced MRI at 3 T is useful for accurate diagnosis of metastatic sentinel nodes, indicating that sentinel node biopsy may be avoided in patients with breast cancer who have non‐metastatic sentinel nodes on imaging.Keywords
This publication has 43 references indexed in Scilit:
- Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancerBritish Journal of Surgery, 2010
- Role of ultrasound‐guided fine‐needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinomaCancer, 2002
- Gamma probe and ultrasonographically-guided fine-needle aspiration biopsy of sentinel lymph nodes in breast cancer patientsEuropean Journal of Surgical Oncology, 2001
- Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancerBritish Journal of Surgery, 1999
- Sentinel node biopsy in breast cancer patients with clinically negative lymph-nodesBreast Cancer, 1999
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998
- Staging of symptomatic primary breast cancer with MR imaging.American Journal of Roentgenology, 1997
- Sentinel lymphadenectomy in breast cancer.Journal of Clinical Oncology, 1997
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994